Fierce Biotech2h
Vertex abandons islet cell-device combo after failing to improve diabetes biomarker
Vertex is ending work on one of its two clinical-stage islet cell treatments after the diabetes therapy looked unlikely to ...
Vertex Pharmaceuticals says VX-264 study did not meet primary endpoint
Vertex Pharmaceuticals (VRTX) announced several updates on the company’s type 1 diabetes portfolio. Vertex has completed enrollment and dosing ...
Vertex Announces Program Updates for Type 1 Diabetes Portfolio
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced several updates on the Company’s type 1 diabetes (T1D) ...
Reuters26d
Starmer navigates Ukraine talks with ‘cool head’ as Trump acts tough
While Starmer has yet to win U.S. security guarantees for Ukraine, he has worked to repair the unprecedented rift in U.S.-Ukraine relations encapsulated by the heated exchange between Zelenskiy ...